Senator Doyle releases Vermont Town Meeting survey results

first_imgSenator Bill Doyle (R-Washington) has released results of his Town Meeting Day survey, with voters supporting a cell phone ban while driving, an increase in the minimum wage and labeling GMO foods, while being torn about the legalization of marijuana, wind turbines and the new health care law.Senator Doyle has been conducting this survey for 44 years. Over 13,000 returns were tabulated from 155 Vermont Cities and Towns. It is an unscientific poll and non-binding, but it has regularly matched hard polling data and often jibed with what ultimately comes out of Montpelier.Doyle said this is the most response he’s ever had to the iconic poll. He said seven or eight of the questions are still in play in the Legislature.”The cell phone issue is very big right now and I think it’s going to pass,” Doyle said. He said the opiate problem, legalizing marijuana and the minimum wage are much on the mind of the public and of lawmakers. He also thought the question on affordability was revealing.”Vermont is losing out on being an affordable place to live,” he said, as housing is relatively high and wages are relatively average.The results, in percentages, follow:                                                                                                                              YES         NO         UNDECIDED1.  Prohibiting drivers from using cell phones                                                        74%       19%       7%2.  Legalization of marijuana                                                                                 44%       45%       11%3.  Wind turbines on Vermont ridgelines                                                               48%       33%       19%4.  Increasing minimum wage                                                                                 71%       20%       9%5.  Concern about opiate use                                                                                89%       5%          6%6.  Reducing prison population for non-violent offenders                                     71%       17%       12%7.  GMO: should food products with genetic engineering be labeled                    76%       15%       9%8.  Do you believe Vermont is an affordable place to live                                      26%       60%       14%9.  Is statewide cell service and broadband important to the future     of Vermont’s economy                                                                                        87%       5%          8%10. Is natural gas an important part of Vermont’s economy                                   55%       21%       24%11. Should Vermont have a state bank                                                                  23%       38%       39%12. Do you believe Vermont healthcare is moving in the right direction                 41%       38%       21%13. Are education costs unsustainable                                                                   69%       18%       13%14. Does the federal government collect too much information       on the lives of citizens                                                                                      69%       17%       14%last_img read more

News Scan for Mar 31, 2015

first_imgPAHO chikungunya count rises by more than 32,000The number of chikungunya infections in the Americas has increased to 1,343,372, a rise of 32,504, the Pan American Health Organization (PAHO) said in its latest update. The bump in cases was slightly higher than the 28,768-case increase recorded the week before.PAHO’s latest count includes 1,310,925 suspected, 28,910 confirmed, and 3,537 imported cases. Most of the imported cases are from the United States, which has 2,549,13 more than the previous week.The US Centers for Disease Control and Prevention (CDC) said in a Mar 24 update that so far 68 chikungunya cases, all of them travel related, have been reported in 19 states so far this year. No locally transmitted cases have been reported. US territories have reported 52 chikungunya cases this year, all of them locally transmitted infections in Puerto Rico and the US Virgin Islands.Most of the increase this week came from Nicaragua, which submitted 10 weeks’ worth of data, and Colombia.The death toll from the disease remained the same at 184.Mar 28 PAHO update Mar 24 CDC update Saudis report another MERS case; camel serum suggested as treatmentSaudi Arabia reported another MERS-CoV (Middle East respiratory syndrome coronavirus) case today, while researchers raised the possibility of using camel antibodies to treat MERS patients.The latest patient is a 65-year-old expatriate woman in Riyadh who is in stable condition, the Saudi Ministry of Health (MOH) reported. She is not a healthcare worker and had no contact with other MERS patients in healthcare or community settings, but the statement did not indicate whether she had any contact with animals.The MOH also announced the death of a 57-year-old Saudi man in Hofuf whose case was reported earlier. In addition, the ministry noted the recovery of a 50-year-old male expatriate in Najran.The latest events raised the MOH’s cumulative MERS count to 973 cases, with 422 deaths, 532 recoveries, and 19 patients still in treatment or home isolation. Mar 31 MOH statementMeanwhile, researchers reported recently in the Journal of Virology that they used antibodies from camels to protect mice from MERS-CoV and to help infected mice recover from the disease.The authors, from the United States and China, wrote that serum from recovered MERS patients may be useful for treating infected persons but is not readily available, and that most camels in the Arabian Peninsula carry MERS-CoV antibodies because of past infections. They used serum from camels to treat mice infected with human MERS-CoV isolates.”The study, a successful proof-of-concept study, showed that prophylactic or therapeutic treatment with high-titer MERS immune camel sera diminished weight loss and pathological changes in lung tissues, and cleared the infections in the mice,” says a press release from the American Society for Microbiology (ASM), publisher of the Journal of Virology.”Our results suggest that these antibodies might prove therapeutic for MERS patients, and might protect uninfected household members and healthcare workers against MERS,” corresponding author Stanley Perlman, MD, PhD, said in the release. He is a professor in the departments of microbiology and pediatrics at the University of Iowa.Mar 18 J Virol study Mar 30 ASM press release Study: Sofosbuvir for hepatitis C cost-effective only in sickest patientsFor cost-effectiveness, oral sofosbuvir-based treatment for hepatitis C virus (HCV) types 2 and 3 would best be reserved for only those patients with advanced liver disease or for whom other treatments have failed, say the authors of a study published yesterday in the Annals of Internal Medicine.The researchers, from Boston Medical Center (BMC), simulated clinical outcomes, measured as quality-adjusted life years (QALYs) gained, and costs in 2013 US dollars for eight treatment strategies, including sofobuvir-based treatments, the first all-oral treatment approved for US HCV infections. They also calculated the incremental cost-effectiveness ratio (ICER) of treatments by dividing additional costs of each treatment into QALYs gained over the next less expensive treatment.They found that for patients with cirrhosis, the ICER of sofosbuvir treatment was less than $100,000 for each QALY gained whether or not patients have been treated previously with other therapies, a cost commonly cited as the “US willingness-to-pay threshold” per QALY gained, say the authors. By contrast, in noncirrhotic HCV patients who are treatment-naive, the cost was calculated as more than $200,000 per QALY gained.The authors give two reasons for the non-cost-effectiveness of sofosbuvir treatment in treatment-naive noncirrhotic HCV patients. First, pegylated interferon-ribavirin, which is less-expensive, has an efficacy rate of about 80% in these patients but is not an option in treatment-experienced patients. Second, the risk of death from HCV is low in patients without cirrhosis, and not all develop cirrhosis, so sofosbuvir therapy does not translate directly into substantial increases in life expectancy in this group.In addition to limiting the candidates for sofosbuvir treatment, the authors say the cost-effectiveness of the treatment could be improved by lowering the cost of the agent. “At its current cost, access to sofosbuvir will likely be unequal and restricted and will limit the number of people ultimately cured of HCV infection in the United States,” they say.Mar 30 Ann Intern Med study abstract Mar 30 BMC press release Resistant infections tied to endoscopes thought to be fully decontaminatedCurrent industry standards for cleaning and maintenance of endoscopes are insufficient for complete decontamination, say the authors of a report on a cluster of antibiotic-resistant Escherichia coli (CRE) infections published yesterday in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA).The cases of 49 patients with AmpC E coli infection who were patients at a hospital in Washington state from January 2012 to August 2013 were reviewed. Gene sequencing showed 35 (71%) of them to have a strain of bacteria with an identical mutation, including all 10 with carbapenem-resistant (CR) infection.All 35 had complicated biliary or pancreatic disease and had undergone endoscopic retrograde cholangiopancreatography (ERCP) at least once during the study period. Mortality at 30 days was 16% overall and 56% for the CR patients.An evaluation of reprocessed ERCP scopes at the hospitalshowed that 2 of 8 were contaminated by the same bacteria on pulsed-field gel electrophoresis. They had all been cleaned at a level exceeding the manufacturer’s guidelines. Environmental cultures were negative, and no breaks in infection-control procedures were known.A press release from SHEA says the hospital has taken “costly and extraordinary measures,” including quarantining and culturing ERCP scopes after cleaning but that even that has not been entirely successful.”We suspect endoscope-associated transmission of pathogenic bacteria might be both more common than recognized and not adequately prevented by current endoscope reprocessing guidelines,” conclude the authors. They suggest re-evaluation of endoscope design and of reprocessing standards and say endoscopists should inform patients of the risk for endoscope-related bacterial transmission.The report comes in the wake of reports in February of antibiotic-resistant infections linked to the use of reusable duodenoscopes in seven patients at a hospital in Los Angeles.Mar 30 Infect Control Hosp Epidemiol study abstract Mar 30 SHEA press release Related Feb 19 CIDRAP News itemlast_img read more

Sponsored: What you should know about holding property

first_imgI am sure you have heard that even famous people don’t always think about how their property should be deeded to them. This information is extremely important for all of us to know and understand, so our intentions are supported by the law on our property.1. Sole ownershipIf you are going to own the property by yourself, one of the ways to hold title to your home is in your name alone. This is also called “ownership in severalty”.When a single person with title to real property is in his or her name decides to get married, the spouse may be asked to sign a quitclaim deed giving up any ownership interest in the property, and they would have to choose among the options listed below.2. Tenants in commonIf you decide to buy real estate with one or more of your friends, and you all will take title, you and your friends often become tenants in common. This may be an option if you buy a home with a friend as an investment. Each of you will have to determine how much interest you want to have. It need not be equal – the shares may be 60-30-10, for instance, depending on how much money was invested or how much work has been assigned.If something happens to one of the friends, their share would go to someone they specified or to their heirs. The challenge is that the other friends would be in ownership with someone they potentially do not know or with whom they would prefer not to be in ownership. Tenancy in common property is subject to probate court costs and all of the challenges that can represent.3. Joint tenancy with right of survivorshipWhen title is held in joint tenancy with right of survivorship, owners may take title at the same time, and they own equal percentage in the property. If something happens to an owner, all of the ownership is passed to the surviving owner(s). This concept will help to avoid probate, and normally, just a death certificate will clear the title into the one owner’s name.4. Living trustMy opinion on the best way to hold title to homes and other real property is in a revocable living trust. There are many advantages, such as avoidance of probate costs, and your wishes are best followed in this manner.There is a potential up-front cost of creating a living trust and deeding real property into the living trust, but there are no negative sides that I can see. Give me a call and I can connect you with a cost-effective attorney who can help you with this.Stocks, bonds, bank accounts, automobiles and other major assets can also be held in a living trust. Since the living trust is revocable, these assets can be bought, sold, and financed as usual.Until the death or disability of the trust creator, the home and other real estate and/or assets in the living trust are treated normally.This would have been a great way for the beloved Aretha Franklin to have placed all of her assets into a trust prior to her passing, so all of her loved ones would have been protected with her wishes.No matter what your questions are, feel free to click on “Ask Annette a Question” or call me. I’m always here earning the right to be your real estate resource and real estate agent!I care about you!Annette Reported by admin Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Pinterest (Opens in new window)last_img read more

Hubchev spoke and made a confession about the situation in Levski…

first_imgLevski coach Petar Hubchev gave his first interview in a long time. The mentor speaks in front of the club’s website. On Friday, the “blues” host Ludogorets in a match of the 25th round of the First League. The specialist commented on the long interruption of football life due to the pandemic of COVID-19, the dynamic processes in the club and his expectations for the matches of the First League and the decisive semifinals for the Cup of Bulgaria against Lokomotiv (Plovdiv).“The boys took it seriously, but it is obvious that there is a lack of playing practice. There was very little time to prepare. All teams will enter the matches without being in optimal shape,” said Hubchev.Winbet – victory is at your fingertips! (18+)“We will emphasize the tactics in the trainings for the match with Ludogorets”, added the coach of the “blues”“This difficult period during the pandemic for Levski turned out to be twice as difficult because of what is happening at the club. The players received timely programs without breaking the rules. However, it seems that all of us were busy with what was happening at the club. is the main problem that concerns us. I think that everyone has coped with this period “, the mentor commented on what happened in recent months.See the whole interview of Petar Hubchev:last_img read more